All In Biotech

Free tool

FAERS Monitor: Survanta

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 020032 or its brand name (Survanta, Beractant). Reports on generic versions are filed under their own applications.

Reports

369

Serious

362

98% of reports

Hospitalization

72

Death reported

222

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pulmonary haemorrhage126
  • death54
  • neurodevelopmental disorder36
  • pneumothorax34
  • drug ineffective33
  • sepsis19
  • neonatal respiratory distress syndrome17
  • endotracheal intubation complication16
  • neonatal disorder16
  • oxygen saturation decreased16
  • respiratory failure15
  • acute respiratory distress syndrome14
  • bradycardia13
  • cardiac arrest11
  • general physical health deterioration7

Reports by year received

View as table
YearReports
200414
200518
20065
20073
200812
20098
20105
201118
201215
201333
201470
201515
201617
201733
201827
201916
202016
20218
202212
20248
202510
20266

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,790 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
neurodevelopmental disorderSignal363209.42330.9106,305
endotracheal intubation complicationSignal161590.4978.123,204
pulmonary haemorrhageSignal126932.9808.3114,537
neonatal disorderSignal16581.8359.48,618
neonatal respiratory distress syndromeSignal17275.2172.84,353
pneumothoraxSignal34122.588.93,971
acute respiratory distress syndromeSignal1445.227.0561
oxygen saturation decreasedSignal1616.210.1214
bradycardiaSignal1314.08.2144
respiratory failureSignal1511.77.1137
sepsisSignal199.76.3141
cardiac arrestSignal117.64.257
deathSignal543.62.8102
general physical health deteriorationSignal73.41.710
drug ineffective331.41.04

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.